Skip to main content
. 2022 Mar 10;186(6):607–617. doi: 10.1530/EJE-21-1228

Table 3.

Overall survival analyses in stage I-IV ACC patients. P-values < 0.05 are indicated in bold.

Univariate analysis Multivariable analysis
HR 95% CI P-value HR 95% CI P-value
Age (per year increase) 1.01 0.99–1.04 0.40
Sex (M vs F) 0.51 0.21–1.23 0.13
Cortisol secretion (yes vs no) 4.04 1.62–10.07 0.003 1.16 0.32–4.13 0.82
ENSAT stage
 III vs I–II 5.68 2.44–13.23 <10−4 8.19 2.41–27.81 0.0007
 IV vs I–II 10.95 4.35–27.54 <10−6 32.34 7.03–148.86 <10−5
Resection status (R1–R2–RX vs R0) 4.88 2.39–9.98 <10−4 0.97 0.35–2.66 0.95
Ki-67 proliferation index
10–19 % vs <10% 2.96 0.66–13.27 0.16 0.81 0.15–4.28 0.80
 ≥20% vs <10% 10.20 3.05–34.12 0.0002 1.79 0.35–9.00 0.48
Molecular class (C1A vs C1B) 10.15 3.09–33.35 0.0001 7.5 1.47–38.13 0.01